The AEESD is a programme within the Plan for Scientific and Technical Research and Innovation 2013-2016, to finance industrial research or experimental development projects in the field of ICTs. Last year's novelty was the increase of the % grant, which can reach 50% for SMEs depending on the qualification. Below are some of the projects from last year's call that received the highest scores.
BBVA had already invested in the Fintech sector in recent years as part of its transformation strategy to become the world's leading international digital bank. It has started 2016 strongly and has expanded its BBVA Ventures fund from $100M to $250M and has reached a management agreement with the US firm Propel Venture Partners.
Good news for startups in our country. Bullnet capital has just closed its third fund with €42M, plus in recent weeks we have witnessed the emergence of new funds for technology startups that are essential to make Spain technologically competitive.
In 2015 we already saw how investment in E-health gained strength in our country, especially thanks to new platforms for finding and contacting doctors, this year we are going a step further and in 2016 it seems that the use of tics for the treatment of diseases will also be one of the preferences of investors.
The purchase of Groupalia and Offerum by Ofertix and La Nevera Roja by Just Eat that we have seen this week are a clear example that in the world of startups you have to know the right time to buy in order to win. Both the online discount market and the food delivery market boomed a few years ago, many startups were created, some of them who wanted to win, decided to grow through acquisitions, paying quite high prices, now these markets can no longer grow more and other startups buy these companies at a much lower price.
Celtic Plus is an industry-led Eureka cluster promoting European R&D projects in the areas of telecommunications, media, Future Internet and ICT applications and services. This year's winter call will be open from 26 February to 25 May. The conditions for this call are expected to be improved, companies will be able to get up to 50% of grant funding, without the need for a loan part.
By 2016, investment in Spanish fintech companies is expected to triple and the number of companies operating in the sector is expected to double. 2015, with 78 companies operating in our country and funding of around €200M, has been the take-off of this sector in Spain, which according to Venture Watch was the protagonist of 9.6% of venture capital operations in Spain.
An innovative entrepreneur is an entrepreneur who is able to differentiate his product from others even in highly competitive markets. Innovation provides an important strategic and competitive advantage and that is why it is so highly valued by investors. In this post we take as an example two Digital Marketing companies, Beabloo and Olapic, which in 2015 received large rounds that have attracted investors because of their great commitment to innovation.
In July 2015, the Oesía Network group restructured its shareholding, giving more prominence to its managers, who have been left with 44% and have carried out a new business plan in which more weight has been given to the engineering and security division.
Manunet is one of the European Commission's network of 15 partners and 8 associates from different countries and regions to promote transnational R&D projects in the field of advanced manufacturing. The call for proposals opened this month of...
In recent years we have seen how Spanish startups have followed the strategy of buying Spanish and international startups to become leaders in their sector. Good examples of this strategy are Parclick, Percentil and GetApp.
In the last few months, three financing rounds totalling almost €70M have taken place in Spain, those of Sanifit, Minoryx and Aelix Therapeutics, and one IPO, that of Oryzon. These figures confirm the boom in the sector, not only for domestic investors but also for foreign investors. This January we have already seen investments such as Inveready's investment in Oncostellae and that of Aelix Therapeutics.